Bristol Myers Squibb results top estimates as new drugs post strong sales growth

Read Time:5 Second

Bristol Myers Squibb also issued its full-year 2024 forecast, which was generally in line with expectations.

About Post Author

Happy

0 %

Sad

0 %

Excited

0 %

Sleepy

0 %

Angry

0 %

Surprise

0 %

Millennium Management’s obsession with not losing money has powered $56 billion in investor gains. Its CEO, Israel “Izzy” Englander, avoids...

Getting out of the deflationary hole China dug itself is vital, and in the short run all stimulus will help....

UniCredit’s effort to buy Germany’s Commerzbank is a test of a broader project to revive Europe’s vitality and stature in...

Rents remain high, but not as high as mortgage payments.

Interest rates are finally coming down. Investors might want to chase the trend, but they don’t need to reach for...

U.S. prosecutors have alleged that TD was reckless in failing to build and maintain systems that flagged and prevented money-laundering.